The company that has developed this promising drug for GPA is ChemoCentryx in Mountain View CA. They will be having a conference call that we can listen on February 26 at 3 pm. This will also be available for the following 2 weeks.
This call will probably be listened to by investors. You can access
I have been following this drug since Pete has brought it to our attention. As a patient who has been unable to discontinue prednisone, this drug may be the answer.
Financial institutions have been pouring a boatload of money into it, along with strong government support.